5071v1 -- (4128,4129) -> C04043

Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, Bohme GA, Laville M, Pratt J, Corti O, Pradier L, Ret G, Joubert C, Periquet M, Araujo F, Negroni J, Casarejos MJ, Canals S, Solano R, Serrano A, Gallego E, Sanchez M, Denefle P, Benavides J, Tremp G, Rooney TA, Brice A, Garcia de Yebenes J

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse.

Hum Mol Genet 12:2277-91 (2003)
DOI:10.1093/hmg/ddg239

Casarejos MJ, Solano RM, Menendez J, Rodriguez-Navarro JA, Correa C, Garcia de Yebenes J, Mena MA

Differential effects of l-DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal-enriched cultures from parkin knockout and wild-type mice.

J Neurochem 94:1005-14 (2005)
DOI:10.1111/j.1471-4159.2005.03249.x

Naoi M, Riederer P, Maruyama W

Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.

J Neural Transm (Vienna) 123:91-106 (2016)
DOI:10.1007/s00702-014-1362-4

Jesko H, Lenkiewicz AM, Wilkaniec A, Adamczyk A

The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease.

Acta Neurobiol Exp (Wars) 79:276-289 (2019)